Waning effectiveness of SARS-CoV-2 mRNA vaccines in older adults: a rapid review
Author:
Affiliation:
1. Precision Vaccines Program, Division of Infectious Diseases, Boston Children’s Hospital, Boston, MA, USA
2. Department of Pediatrics, Harvard Medical School, Boston, MA, USA
3. Broad Institute of MIT & Harvard, Cambridge, MA, USA
Funder
NIH/NIAID
Publisher
Informa UK Limited
Subject
Pharmacology,Immunology,Immunology and Allergy
Link
https://www.tandfonline.com/doi/pdf/10.1080/21645515.2022.2045857
Reference25 articles.
1. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
2. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
3. Factors associated with COVID-19-related death using OpenSAFELY
4. Effectiveness of COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Frontline Workers Before and During B.1.617.2 (Delta) Variant Predominance — Eight U.S. Locations, December 2020–August 2021
5. Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant — National Healthcare Safety Network, March 1–August 1, 2021
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Multiple vaccine comparison in the same adults reveals vaccine-specific and age-related humoral response patterns: an open phase IV trial;Nature Communications;2024-08-04
2. Adjuvantation of a SARS-CoV-2 mRNA vaccine with controlled tissue-specific expression of an mRNA encoding IL-12p70;Science Translational Medicine;2024-07-24
3. Age differentially impacts adaptive immune responses induced by adenoviral versus mRNA vaccines against COVID-19;Nature Aging;2024-06-25
4. The aged tumor microenvironment limits T cell control of cancer;Nature Immunology;2024-05-14
5. Multiple vaccine comparison in the same adults from the VITAL study reveals vaccine-specific and age-related humoral response patterns;2024-01-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3